Dr. Saito is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2011 Zonal Avenue,
HMR801A
Los Angeles, CA 90033Phone+1 323-442-5100
Summary
- Dr. Takeshi Saito is a gastroenterologist in Los Angeles, CA and is affiliated with multiple hospitals in the area, including Keck Hospital of USC and LAC+USC Medical Center. He received his medical degree (M.D.) and Ph.D. from Showa University, School of Medicine in Tokyo, Japan, and has been in practice 23 years. He also speaks multiple languages, including Japanese. He specializes in hepatology & liver transplantation.
Education & Training
- University of WashingtonPost-Doctoral Fellowship, 2007 - 2009
- University of Texas Southwestern Medical CenterPost-Doctoral Fellowship, 2005 - 2007
- Showa University School of MedicineClass of 1998, MD and PhD
Certifications & Licensure
- CA State Medical License 2012 - 2026
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- Elected to the American Society for Clinical Investigation (ASCI) Member American Society for Clinical Investigation, 2024
Publications & Presentations
PubMed
- 4 citationsFunction of hepatocyte spheroids in bioactive microcapsules is enhanced by endogenous and exogenous hepatocyte growth factor.Kihak Gwon, Daheui Choi, José M de Hoyos-Vega, Harihara Baskaran, Alan M Gonzalez-Suarez
Bioactive Materials. 2023-10-01 - 5 citationsGuiding Hepatic Differentiation of Pluripotent Stem Cells Using 3D Microfluidic Co-Cultures with Human Hepatocytes.Pouria Fattahi, Jose M de Hoyos-Vega, Jong Hoon Choi, Caden D Duffy, Alan M Gonzalez-Suarez
Cells. 2023-08-01 - 17 citationsMacrophages activated by hepatitis B virus have distinct metabolic profiles and suppress the virus via IL-1β to downregulate PPARα and FOXO3.Yumei Li, Yanwen Zhu, Shu Feng, Yuji Ishida, Tsu-Pei Chiu
Cell Reports. 2022-01-25
Press Mentions
- Research Links Specific Bacteria With Worse SBP OutcomesOctober 28th, 2021
- A Case of Benign Hepatic Cyst with Supra-Elevated Cyst Fluid Tumor MarkersJanuary 6th, 2021
- Hepatic Angiosarcoma with Clinical and Histological Features of Kasabach-Merritt SyndromeApril 7th, 2017
- Join now to see all
Committees
- Standing study section member, NIH HBPP Study Section 2022 - Present
- Editorial Board, Journal of Virology 2018 - Present
- AGA Institute Research Awards Panel, American Gastroenterological Association (AGA) 2018 - Present
- Associate Editor, Digestive Diseases and Sciences 2017 - Present
- Research Awards Committee, AASLD 2020 - 2022
Professional Memberships
- Member
- Member
- American Association for the Study of Liver DiseasesMember
Other Languages
- Japanese
External Links
- Saito Laboratoryhttps://sites.usc.edu/saito-lab/
- LinkedInhttps://www.linkedin.com/in/takeshi-saito-a4aa6429/
- ResearchGatehttps://www.researchgate.net/profile/Takeshi-Saito-5
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: